Assessment of asymptomatic fungal infections in COVID-19 positive and COVID-19 negative pneumonia: A comprehensive epidemiological analysis
Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: The COVID-19 pandemic has underscored the impact of secondary fungal infections on patient outcomes. This single-center study explores asymptomatic fungal infections in COVID-19-positive and COVID-19-negative pneumonia cases, elucidating the intricate relationship between viral respiratory illnesses and fungal co-infections. Methods: Conducted at a single center, this cross-sectional study examines the prevalence, risk factors, and clinical implications of asymptomatic fungal infections in patients with COVID-19-positive and COVID-19-negative pneumonia. Various demographic, clinical, and laboratory parameters were analyzed. Results: value of 0.016309. Furthermore, COVID-19-positive patients exhibited distinct clinical characteristics, including increased use of remdesivir (94%), higher rates of invasive mechanical ventilation (36%), and a prolonged hospital stay (14.29 days). Conclusion: This study sheds light on the heightened vulnerability to asymptomatic fungal infections in COVID-19-positive pneumonia cases. Understanding these infections prevalence and their associated factors is crucial for comprehensive patient care and may influence treatment strategies, emphasizing the need for targeted interventions in viral respiratory illnesses.
Authors: Dheerendra Kumar Mishra, Pramod Kushwaha, Pooja Gangwar, Ajeet Singh, Umesh Pratap Singh
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $450
OpenAlex ID: W4406305592
